Overall, the pathogenesis of SS appears to be predominantly characterised by the Th1 signature, although the presence of a Th2 signature with modestly increased expression of IL‐4, IL‐5 and IL‐13 has also been reported [16]. The gene discussed is IL13; the disease is synovial sarcoma.